CME COURSE AREAS AND COORDINATORS
|
| |
| Chair Person of the CME activities: |
R. Coppo |
| Assistants: |
G. Spasovski, I. Rychlik |
| Basic Science & Clinical Nephrology: |
R. Coppo, P. Ronco |
| Chronic Renal Failure, Hypertension, Clinical Epidemiology: |
C. Zoccali, G. M. London |
| Dialysis: |
R. Vanholder, S. Davies, C. Wanner |
| Transplantation: |
C. Ponticelli, J.M. Grinyo |
| Collaboration with ISN and other Societies: |
N. Lameire, A. Covic |
|
|
| Date |
| April 25, 2009 |
| |
| Location |
Macedonian Academy of Sciences and Arts
|
| |
| Organising Societies |
Macedonian Society of Nephrology, Dialysis, Transplantation and Artificial Organs in cooperation with ERA-EDTA & ISN/COMGAN |
| |
| Local Coordinator |
Assoc. Prof. Goce B Spasovski, MD, PhD , E-mail: gspas@sonet.com.mk
|
| Fax: +389 2 3220 935 |
| |
| Short Description |
The problem of the increasing number of CKD patients, diagnostic and treatment options based on the latest evidence will be discussed during this whole day course. |
| |
| Travel Grant |
|
| To apply for travel grant please click here |
| |
| Details/General Information |
Available soon |
| |
| Course Programme |
| |
Preliminary programme |
| 1. CKD global outlook: Myth and Reality, Nahas M (UK) |
| 2. Early detection and treatment of primary glomerulopathies, Feehally J (UK) |
| 3. Diagnostic and treatment risks of metal toxicity in nephrology, De Broe M (Belgium) |
| 4. Anemia treatment in CKD, ESRD and Kidney transplant recipients, TBA (KUE-invited) |
| 5. Oxidative stress and cardiovascular risks in CKD patients, Massy Z (France) |
| 6. Effect of treatment with Vit. D - pros et cons (TBC), Cannata J (Spain) |
| 7. Treatment of hyperphosphatemia, benefit and/or hazard, Spasovski G (MK) |
| 8. Bone, blood vessels and related cardiovascular consequences in dialysis patients, London G (France) |
| 9. Advantages of treatment in dialysis patients with new membranes and dialysis equipments (MPO, HEMO, & other issues), Vanholder R (Belgium) |
| 10. Extracorporeal blood purification in sepsis - nonsense or new hope, Falkenhagen (Austria) |
|
08.00-08.30 Registration
08.30-09.00 Welcome address: H. Klinkmann, G. London, M. De Broe, G. Spasovski
09.00-09.40 CKD global outlook: Myth and Reality, Nahas ME (UK)
09.40-10.20 Early detection and treatment of primary glomerulopathies, Feehally J (UK)
10.20-11.00 Diagnostic and treatment risks of metal toxicity in nephrology, De Broe M (Belgium)
11.00-11.30 Coffee break
11.30-12.10 Anemia treatment in CKD, ESRD and Kidney transplant recipients, Macdougall I (UK)
12.10-12.50 Oxidative stress and cardiovascular risks in CKD patients, Massy Z (France)
12.50-13.30 Effect of treatment with Vit. D - pros et cons, Cannata J (Spain)
13.30-14.30 Lunch
14.30-15.10 Treatment of hyperphosphatemia, benefit and/or hazard, Spasovski G (MK)
15.10-15.50 Bone, blood vessels and related cardiovascular consequences in dialysis patients, London G (France)
15.50-16.20 Coffee break
16.20-17.00 Advantages of treatment in dialysis patients with new membranes and dialysis equipments, Vanholder R (Belgium)
17.00-17.40 Extracorporeal blood purification in sepsis - nonsense or new hope, Falkenhagen D (Austria)
17.40-18.00 Closing remarks |
TOP
|
|
